Fremslife is an Italian start-up that designs, develops, manufactures and markets innovative technologies for health and well-being.
The innovative and integrated proposal that Fremslife has developed for physiotherapy, functional rehabilitation and the cure and reduction of pain in neurovascular diseases exploits the effectiveness and scientific validation of the innovative, patented and certified Frems™ technology (Frequency Rhythmic Electrical Modulation System).
Frems™ is the only scientifically validated neuro-stimulation that exerts an action of neo-angiogenesis by promoting the release and synthesis of vascular endothelial growth factors. Already from the first session it promotes the reduction of pain. It is ideal for treating pathologies and traumas in the acute stage, it integrates perfectly with other rehabilitation systems and provides excellent results, particularly appreciated by patients who are refractory to other therapies or treatments.
The product portfolio is completed by a device for tecar therapy, an ultra-low-power laser and a stabilometric platform.
The integrated solution that Fremslife proposes has its foundation in scientific research, contemplates training, is oriented towards prevention and focuses on pain reduction, a fundamental premise for rehabilitation. Each point of this strategy converges towards the goal of enabling professionals to provide reliable and measurable certified results.
Fremslife’s mission is to be the bearer of new technologies, supported by the latest scientific developments, in order to ensure results that improve the quality of life.
For the treatment of pain and functional recovery
For a quick functional recovery thanks to the total man/device synergy
For the treatment of musculoskeletal pain
For the evaluation of motor function and balance in standing position